6

AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 2: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 3: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 4: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 5: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is
Page 6: AEX32 Print - Centers for Disease Control and Prevention · that Genentech's HMWP drugs, rituximab and bevacizumab, do not meet the criteria for a hazardous drugs. This position is